Hepatectomy-related hypophosphatemia: A novel phosphaturic factor in the liver-kidney axis

Journal of the American Society of Nephrology

Volumn 25, Issue 4, 2014, Pages 761-772

  Nomura, Kengo ^a   Tatsumi, Sawako ^a   Miyagawa, Atsumi ^a   Shiozaki, Yuji ^a   Sasaki, Shohei ^a   Kaneko, Ichiro ^a   Ito, Mikiko ^a   Kido, Shinsuke ^a   Segawa, Hiroko ^a   Sano, Mitsue ^b   Fukuwatari, Tsutomu ^b   Shibata, Katsumi ^b   Miyamoto, Ken Ichi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b UNIVERSITY OF SHIGA PREFECTURE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; CREATININE; NICOTINAMIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PARATHYROID HORMONE; PHOSPHATE; SODIUM; ACRYLAMIDE DERIVATIVE; N (4 (1 BENZOYLPIPERIDIN 4 YL)BUTYL) 3 (PYRIDIN 3 YL)ACRYLAMIDE; N-(4-(1-BENZOYLPIPERIDIN-4-YL)BUTYL)-3-(PYRIDIN-3-YL)ACRYLAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; PIPERIDINE DERIVATIVE; SODIUM PHOSPHATE COTRANSPORTER; SODIUM PHOSPHATE COTRANSPORTER 2A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CREATININE URINE LEVEL; ENZYME INDUCTION; ENZYME MECHANISM; GENE OVEREXPRESSION; HUMAN; HYPOPHOSPHATEMIA; IN VITRO STUDY; INTESTINE BRUSH BORDER MEMBRANE; KIDNEY CELL; KIDNEY CORTEX; KIDNEY PROXIMAL TUBULE; LIVER RESECTION; MALE; MOUSE; NONHUMAN; PARTIAL HEPATECTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; URINE LEVEL; ANIMAL; C57BL MOUSE; KIDNEY; METABOLISM; PARATHYROIDECTOMY; PHYSIOLOGY; WISTAR RAT;

ACRYLAMIDES; ANIMALS; HEPATECTOMY; HYPOPHOSPHATEMIA; KIDNEY; MALE; MICE; MICE, INBRED C57BL; NAD; NIACINAMIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PARATHYROIDECTOMY; PIPERIDINES; RATS; RATS, WISTAR; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE IIA;

EID: 84901390869     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013060569     Document Type: Article

References (48)

1. Murer H, Hernando N, Forster I, Biber J: Proximal tubular phosphate reabsorption: Molecularmechanisms. Physiol Rev80:1373-1409, 2000
2. Miyamoto K, Haito-Sugino S, Kuwahara S, Ohi A, Nomura K, Ito M, Kuwahata M, Kido S, Tatsumi S, Kaneko I, Segawa H: Sodium-dependent phosphate cotransporters: Lessons from gene knockout and mutation studies. JPharm Sci 100: 3719-3730, 2011
3. Berndt T, Kumar R: Phosphatonins and the regulation of phosphate homeostasis. Annu Rev Physiol 69: 341-359, 2007
4. Quarles LD: Endocrine functions of bone in mineral metabolism regulation. JClin Invest 118: 3820-3828, 2008
5. Shimada T, Mizutani S, MutoT, YoneyaT, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T: Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98: 6500-6505, 2001
6. Liu S, Quarles LD: How fibroblast growth factor 23 works. JAmSoc Nephrol 18: 1637-1647, 2007
7. Juppner H, Wolf M, Salusky IB: FGF-23: More than a regulator of renal phosphate handling? JBoneMiner Res 25: 2091-2097, 2010
8. White SA, Al-MukhtarA, LodgeJP, Pollard SG: Progress in living donor liver transplantation. Transplant Proc 36: 2720-2726, 2004
9. Buell JF, Berger AC, Plotkin JS, Kuo PC, Johnson LB: The clinical implications of hypophosphatemia following major hepatic resection or cryosurgery. Arch Surg 133: 757-761, 1998
10. Pomposelli JJ, Pomfret EA, Burns DL, Lally A, Sorcini A, Gordon FD, Lewis WD, Jenkins R: Life-threatening hypophosphatemia after right hepatic lobectomy for live donor adult liver transplantation. Liver Transpl 7: 637-642, 2001
11. Datta HK, Malik M, Neely RD: Hepatic surgery-related hypophosphatemia. Clin Chim Acta 380: 13-23, 2007
12. Giovannini I, Chiarla C, Nuzzo G: Pathophysiologic and clinical correlates of hypophosphatemia and the relationship with sepsis and outcome in postoperative patients after hepatectomy. Shock 18:111-115, 2002
13. Salem RR, Tray K: Hepatic resection-related hypophosphatemia is of renal origin as manifested by isolated hyperphosphaturia. Ann Surg 241: 343-348, 2005
14. Nafidi O, Lapointe RW, Lepage R, Kumar R, D'Amour P: Mechanisms of renal phosphate loss in liver resection-associated hypophosphatemia. Ann Surg 249: 824-827, 2009
15. Katai K, Tanaka H, Tatsumi S, Fukunaga Y, Genjida K, Morita K, Kuboyama N, Suzuki T, Akiba T, Miyamoto K, Takeda E: Nicotinamide inhibits sodium-dependent phosphate cotransport activity in rat small intestine. Nephrol Dial Transplant 14: 1195-1201, 1999
16. Kempson SA, Colon-Otero G, Ou SY, Turner ST, Dousa TP: Possible role of nicotinamide adenine dinucleotide as an intracellular regulator of renal transport of phosphate in the rat. J Clin Invest 67: 1347-1360, 1981
17. Wu KI, Bacon RA, Al-Mahrouq HA, Kempson SA: Nicotinamide as a rapid-acting inhibitor of renal brush-border phosphate transport. Am J Physiol 255: F15-F21, 1988
18. Takahashi Y, Tanaka A, Nakamura T, Fukuwatari T, Shibata K, Shimada N, Ebihara I, Koide H: Nicotinamide suppresses hyperphosphatemia in hemodialysis patients. Kidney Int 65: 1099-1104, 2004
19. Martin PR, Shea RJ, Mulks MH: Identification of a plasmid-encoded gene from Haemophilus ducreyi which confers NAD independence. J Bacteriol 183: 1168-1174, 2001
20. Revollo JR, Grimm AA, Imai S: The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem 279: 50754-50763, 2004
21. Zhang LQ, Heruth DP, Ye SQ: Nicotinamide phosphoribosyltransferase in human diseases. J Bioanal Biomed 3: 13-25, 2011
22. Imai S: The NAD World: A new systemic regulatory network for metabolism and aging-Sirt1, systemic NAD biosynthesis, and their importance. Cell Biochem Biophys 53: 65-74, 2009
23. Imai S: From heterochromatin islands to the NAD World: Ahierarchical view of aging through the functions of mammalian Sirt1 and systemic NAD biosynthesis. Biochim Biophys Acta 1790: 997-1004, 2009
24. Segawa H, Yamanaka S, Onitsuka A, Tomoe Y, Kuwahata M, Ito M, Taketani Y, Miyamoto K: Parathyroid hormone-dependentendocytosis of renal type IIc Na-Pi cotransporter. Am J Physiol Renal Physiol 292: F395-F403, 2007
25. Shibata K, Kakehi H, Matsuo H: Niacin catabolism in rodents. JNutrSci Vitaminol (Tokyo) 36: 87-98, 1990
26. Collins PB, Chaykin S: The management of nicotinamide and nicotinic acid in the mouse. J Biol Chem 247: 778-783, 1972
27. Bender DA, Olufunwa R: Utilization of tryptophan, nicotinamide and nicotinic acid as precursors for nicotinamide nucleotide synthesis in isolated rat liver cells. Br J Nutr 59: 279-287, 1988
28. Ferris GM, Clark JB: Nicotinamide nucleotide synthesis in regenerating rat liver. Biochem J 121: 655-662, 1971
29. Ferris GM, Clark JB: The control of nucleic acid and nicotinamide nucle-otide synthesis in regenerating rat liver. Biochem J 128: 869-877, 1972
30. Imai S: Dissecting systemic control of metabolism and aging in the NAD World: The importance of SIRT1 and NAMPT-mediated NAD biosynthesis. FEBS Lett 585: 1657-1662, 2011
31. Pittelli M, Formentini L, Faraco G, Lapucci A, Rapizzi E, Cialdai F, Romano G, Moneti G, Moroni F, Chiarugi A: Inhibition ofnicotinamide phosphoribosyltransferase: Cellular bioenergetics reveals a mito-chondrial insensitive NAD pool. J Biol Chem 285: 34106-34114, 2010
32. Hasmann M, Schemainda I: FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res 63: 7436-7442, 2003
33. Dousa TP: Modulation of renal Na-Pi cotransport by hormones acting via genomic mechanism and by metabolicfactors. Kidney Int49:997-1004, 1996
34. Tenenhouse HS, Chu YL: Hydrolysis of nicotinamide-adenine di-nucleotide by purified renal brush-border membranes. Mechanism of NAD+ inhibition of brush-border membrane phosphate-transport activity. Biochem J 204: 635-638, 1982
35. Campbell PI, al-Mahrouq HA, Abraham MI, Kempson SA: Specificin-hibition of rat renal Na+/phosphate cotransport by picolinamide. J Pharmacol Exp Ther 251: 188-192, 1989
36. Takahashi F, Morita K, Katai K, Segawa H, Fujioka A, Kouda T, Tatsumi S, Nii T, Taketani Y, Haga H, Hisano S, Fukui Y, Miyamoto KI, Takeda E: Effects of dietary Pi on the renal Na+-dependent Pi transporter NaPi-2 in thyroparathyroidectomized rats. Biochem J 333: 175-181, 1998
37. Higgins GM, Anderson RM: Experimental pathology of the liver: I. Restoration of the liver in the white rat following partial remova. Arch Pathol (Chic) 12: 186-202, 1931
38. Inoue Y, Segawa H, Kaneko I, Yamanaka S, Kusano K, Kawakami E, Furutani J, Ito M, Kuwahata M, Saito H, Fukushima N, Kato S, Kanayama HO, Miyamoto K: Role of the vitamin D receptor in FGF23 action on phosphate metabolism. Biochem J 390: 325-331, 2005
39. Segawa H, Onitsuka A, Kuwahata M, Hanabusa E, Furutani J, Kaneko I, TomoeY, Aranami F, Matsumoto N, Ito M, Matsumoto M, Li M, Amizuka N, Miyamoto K: Type IIc sodium-dependent phosphate transporter regulates calcium metabolism. J Am Soc Nephrol 20: 104-113, 2009
40. Katai K, Segawa H, Haga H, Morita K, Arai H, Tatsumi S, Taketani Y, Miyamoto K, Hisano S, Fukui Y, Takeda E: Acute regulation by dietary phosphate of the sodium-dependent phosphate transporter (NaP(i)-2) in rat kidney. J Biochem 121: 50-55, 1997
41. Segawa H, Kaneko I, Takahashi A, Kuwahata M, Ito M, Ohkido I, Tatsumi S, Miyamoto K: Growth-related renal type II Na/Pi co-transporter. J Biol Chem 277: 19665-19672, 2002
42. Segawa H, Kaneko I, Yamanaka S, Ito M, Kuwahata M, Inoue Y, Kato S, Miyamoto K: Intestinal Na-P(i) cotransporter adaptation to dietary P(i) content in vitamin D receptor null mice. Am J Physiol Renal Physiol 287: F39-F47, 2004
43. Ito M, Sakurai A, Hayashi K, Ohi A, Kangawa N, Nishiyama T, Sugino S, Uehata Y, Kamahara A, Sakata M, Tatsumi S, Kuwahata M, Taketani Y, Segawa H, Miyamoto K: An apical expression signal ofthe renal type IIc Na+-dependent phosphate cotransporter in renal epithelial cells. Am J Physiol Renal Physiol 299: F243-F254, 2010
44. Ohi A, Hanabusa E, Ueda O, Segawa H, Horiba N, Kaneko I, Kuwahara S, Mukai T, Sasaki S, Tominaga R, Furutani J, Aranami F, Ohtomo S, Oikawa Y, Kawase Y, Wada NA, Tachibe T, Kakefuda M, Tateishi H, Matsumoto K, Tatsumi S, Kido S, Fukushima N, Jishage K, Miyamoto K: Inorganic phosphate homeostasis in sodium-dependent phosphate cotransporter Npt2b7" mice. Am J Physiol Renal Physiol 301: F1105-F1113, 2011
45. Fukuwatari T, Morikawa Y, Hayakawa F, Sugimoto E, Shibata K: Influence of adenine-induced renal failure on tryptophan-niacin metabolism in rats. Biosci Biotechnol Biochem 65: 2154-2161, 2001
46. Shibata K, Kawada T, Iwai K: Simultaneous micro-determination of nicotinamide and its major metabolites, N1-methyl-2-pyridone-5-carboxamide and N1-methyl-4-pyridone-3-carboxamide, byhigh-performance liquid chromatography. J Chromatogr A 424: 23-28, 1988
47. SegawaH, YamanakaS, OhnoY, OnitsukaA, ShiozawaK, AranamiF, Furutani J, Tomoe Y, Ito M, Kuwahata M, Imura A, Nabeshima Y, Miyamoto K: Correlation between hyperphosphatemia and type II Na-Pi cotransporter activity in klotho mice. Am J Physiol Renal Physiol 292: F769-F779, 2007
48. Haito-Sugino S, Ito M, Ohi A, Shiozaki Y, Kangawa N, Nishiyama T, Aranami F, Sasaki S, Mori A, Kido S, Tatsumi S, Segawa H, Miyamoto K: Processing and stability of type I Ic sodium-dependent phosphate co-transporter mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria. Am J Physiol Cell Physiol 302: C1316-C1330, 2012